NYSE ARCA | ETF
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 4.19% |
| TERN | Terns Pharmaceuticals Inc | Healthcare | Biotechnology | 4.00% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.98% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.74% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 3.73% |
| NUVB | Nuvation Bio Inc | Healthcare | Biotechnology | 3.34% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 3.30% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 3.09% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.93% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.85% |
| WVE | Wave Life Sciences Ltd | Healthcare | Biotechnology | 2.82% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 2.67% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.63% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 2.62% |
| LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 2.62% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 2.61% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 2.58% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 2.54% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.48% |
| OCUL | Ocular Therapeutix Inc | Healthcare | Biotechnology | 2.46% |